ADAPTIMMUNE THERAPEUTICS PLC Interest Income, Debt Securities, Available-for-sale, Operating
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Interest Income, Debt Securities, Available-for-sale, Operating of $2.10 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeDebtSecuritiesAvailableForSaleOperating · last filed 2024-11-13
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for the quarter ending 2024-09-30 was $2.10M, a 2.47% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for the quarter ending 2024-06-30 was $1.38M, a 10.82% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for the quarter ending 2024-03-31 was $1.34M, a 98.96% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for the quarter ending 2023-12-31 was $1.60M, a 205.16% increase year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for fiscal 2023 was $5.96M, a 286.77% increase from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for fiscal 2022 was $1.54M, a 40.82% increase from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for fiscal 2021 was $1.09M, a 52.66% decline from fiscal 2020.
- ADAPTIMMUNE THERAPEUTICS PLC interest income, debt securities, available-for-sale, operating for fiscal 2020 was $2.31M, a 16.56% decline from fiscal 2019.
| Period end | Interest Income, Debt Securities, Available-for-sale, Operating 3 month | Interest Income, Debt Securities, Available-for-sale, Operating 6 month | Interest Income, Debt Securities, Available-for-sale, Operating 9 month | Interest Income, Debt Securities, Available-for-sale, Operating 12 month |
|---|---|---|---|---|
| 2024-09-30 | $2.10M 10-Q · filed 2024-11-13 | $3.47M derived: sum of 2 quarters · filed 2024-11-13 | $4.82M 10-Q · filed 2024-11-13 | $6.41M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $1.38M 10-Q · filed 2024-08-12 | $2.72M 10-Q · filed 2024-08-12 | $4.32M derived: sum of 3 quarters · filed 2024-08-12 | $6.47M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-03-31 | $1.34M 10-Q · filed 2024-05-15 | $2.94M derived: sum of 2 quarters · filed 2024-05-15 | $5.09M derived: sum of 3 quarters · filed 2024-11-13 | $6.63M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $3.75M derived: sum of 2 quarters · filed 2024-11-13 | $5.29M derived: sum of 3 quarters · filed 2024-11-13 | $5.96M 10-K · filed 2024-03-06 |
| 2023-09-30 | $2.15M 10-Q · filed 2024-11-13 | $3.69M derived: sum of 2 quarters · filed 2024-11-13 | $4.37M 10-Q · filed 2024-11-13 | $4.89M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.54M 10-Q · filed 2024-08-12 | $2.22M 10-Q · filed 2024-08-12 | $2.74M derived: sum of 3 quarters · filed 2024-08-12 | $3.07M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $676.00K 10-Q · filed 2024-05-15 | $1.20M derived: sum of 2 quarters · filed 2024-05-15 | $1.52M derived: sum of 3 quarters · filed 2024-05-15 | $1.88M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $847.00K derived: sum of 2 quarters · filed 2024-03-06 | $1.20M derived: sum of 3 quarters · filed 2024-03-06 | $1.54M 10-K · filed 2024-03-06 |
| 2022-09-30 | $324.00K 10-Q · filed 2023-11-08 | $681.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.02M 10-Q · filed 2023-11-08 | $1.20M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $357.00K 10-Q · filed 2023-08-09 | $695.00K 10-Q · filed 2023-08-09 | $874.00K derived: sum of 3 quarters · filed 2024-03-06 | $1.10M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | $338.00K 10-Q · filed 2023-05-12 | $517.00K derived: sum of 2 quarters · filed 2024-03-06 | $742.00K derived: sum of 3 quarters · filed 2024-03-06 | $1.01M derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $404.00K derived: sum of 2 quarters · filed 2024-03-06 | $670.00K derived: sum of 3 quarters · filed 2024-03-06 | $1.09M 10-K · filed 2024-03-06 |
| 2021-09-30 | $225.00K 10-Q · filed 2022-11-08 | $491.00K derived: sum of 2 quarters · filed 2022-11-08 | $916.00K 10-Q · filed 2022-11-08 | -$795.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $266.00K 10-Q · filed 2022-08-04 | $691.00K 10-Q · filed 2022-08-04 | -$1.02M derived: sum of 3 quarters · filed 2023-03-06 | $1.13M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $425.00K 10-Q · filed 2022-05-09 | -$1.29M derived: sum of 2 quarters · filed 2023-03-06 | $861.00K derived: sum of 3 quarters · filed 2023-03-06 | $2.01M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $436.00K derived: sum of 2 quarters · filed 2023-03-06 | $1.58M derived: sum of 3 quarters · filed 2023-03-06 | $2.31M 10-K · filed 2023-03-06 |
| 2020-09-30 | $2.15M 10-Q · filed 2021-11-04 | $3.29M derived: sum of 2 quarters · filed 2021-11-04 | $4.02M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $1.15M 10-Q · filed 2021-08-09 | $1.88M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $730.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $2.77M 10-K · filed 2022-03-14 | |||
| 2018-12-31 | $2.85M 10-K · filed 2021-02-25 |